Loading…

Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments

In recent years, with population aging and economic development, morbidity and mortality of atherosclerotic cardiovascular disease associated with atherosclerosis (AS) have gradually increased. In this study, a combination of network pharmacology and experimental verification was used to systematica...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2023-06, Vol.102 (26), p.e34178-e34178
Main Authors: Huang, Hong-Tao, Lv, Wen-Qing, Xu, Fei-Yue, Wang, Xiao-Long, Yao, Yi-Li, Su, Li-Jie, Zhao, Han-Jun, Huang, Yu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3
cites cdi_FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3
container_end_page e34178
container_issue 26
container_start_page e34178
container_title Medicine (Baltimore)
container_volume 102
creator Huang, Hong-Tao
Lv, Wen-Qing
Xu, Fei-Yue
Wang, Xiao-Long
Yao, Yi-Li
Su, Li-Jie
Zhao, Han-Jun
Huang, Yu
description In recent years, with population aging and economic development, morbidity and mortality of atherosclerotic cardiovascular disease associated with atherosclerosis (AS) have gradually increased. In this study, a combination of network pharmacology and experimental verification was used to systematically explore the action mechanism of Yiqi Huoxue Huatan Recipe (YHHR) in the treatment of coronary atherosclerotic heart disease (CAD). We searched and screened the active ingredients of Coptis chinensis, Astragalus membranaceus, Salvia miltiorrhiza, and Hirudo. We also searched multiple databases for related target genes corresponding to the compounds and CAD. STRING was used to construct the protein-protein interaction (PPI) network of genes. Metascape was used to perform gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for common targets to analyze the main pathways, and finally, the molecular docking and main possible pathways were verified by experimental studies. Firstly, a total of 1480 predicted target points were obtained through the Swiss Target Prediction database. After screening, merging, and deleting duplicate values, a total of 768 targets were obtained. Secondly, “Coronary atherosclerotic heart disease” was searched in databases such as the OMIM, GeneCards, and TTD. 1844 disease-related targets were obtained. Among PPI network diagram of YHHR-CAD, SRC had the highest degree value, followed by AKT1, TP53, hsp90aa1 and mapk3. The KEGG pathway bubble diagram was drawn using Chiplot, the Signal pathways such as NF kappa B signaling pathway, Lipid and AS, and Apelin signaling pathway are closely related to the occurrence of CAD. The PCR and Western blot methods were used to detect the expression of NF-κB p65. When compared with that in the model group, the expression of NF-κB p65mRNA decreased in the low-concentration YHHR group, with P < .05, while the expression of NF-κB p65mRNA decreased significantly in the high-concentration YHHR group, with P < .01. On the other hand, when compared with that in the model group, the expression of NF-κB p65 decreased in the low-concentration YHHR group, but was not statistically significant, while the expression of NF-κB p65 was significant in the high-concentration YHHR group, and has statistical significance with P < .05. YHHR has been shown to resist inflammation and AS through the SRC/NF-κB signaling pathway.
doi_str_mv 10.1097/MD.0000000000034178
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10313272</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2832572329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3</originalsourceid><addsrcrecordid>eNpdkc9u1DAQxi1ERZfCEyAhH7mk-G-8OSHUAkXqqhc4cLIce7IxTeLUdtjyBjw23m4pUB880sxvvhn7Q-gVJaeUNOrt5vyU_D1cULV-glZU8rqSTS2eohUhTFaqUeIYPU_pOyGUKyaeoWOueEMYb1bo1wZsbyafRhw6_M3feHyxhNsFSjDZTDiC9TNgP-HcA84RTB5hynvahhgmE39iU0oxJDuUO3uLnU9gUqH7GJZtjyfIuxCv8dybOBobhrAtTZPDcDtD9Hu99AIddWZI8PI-nqCvHz98ObuoLq8-fT57f1lZISmtQNWSAkBXg1DcUUtb6TpBO1AWOuJk6yyvzVqKVjWtlLa1DXOmk25dO9G1_AS9O-jOSzuCs2V2NIOeyxrlKToYr_-vTL7X2_BDU8IpZ4oVhTf3CjHcLJCyHn2yMAxmgrAkzdacycKxpqD8gNryPSlC9zCHEr03UW_O9WMTS9frf1d86PnjWgHEAdiFIUNM18Oyg6h7MEPu7_SkaljFCkxqTkhVMpTy38qlrPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2832572329</pqid></control><display><type>article</type><title>Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Huang, Hong-Tao ; Lv, Wen-Qing ; Xu, Fei-Yue ; Wang, Xiao-Long ; Yao, Yi-Li ; Su, Li-Jie ; Zhao, Han-Jun ; Huang, Yu</creator><creatorcontrib>Huang, Hong-Tao ; Lv, Wen-Qing ; Xu, Fei-Yue ; Wang, Xiao-Long ; Yao, Yi-Li ; Su, Li-Jie ; Zhao, Han-Jun ; Huang, Yu</creatorcontrib><description>In recent years, with population aging and economic development, morbidity and mortality of atherosclerotic cardiovascular disease associated with atherosclerosis (AS) have gradually increased. In this study, a combination of network pharmacology and experimental verification was used to systematically explore the action mechanism of Yiqi Huoxue Huatan Recipe (YHHR) in the treatment of coronary atherosclerotic heart disease (CAD). We searched and screened the active ingredients of Coptis chinensis, Astragalus membranaceus, Salvia miltiorrhiza, and Hirudo. We also searched multiple databases for related target genes corresponding to the compounds and CAD. STRING was used to construct the protein-protein interaction (PPI) network of genes. Metascape was used to perform gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for common targets to analyze the main pathways, and finally, the molecular docking and main possible pathways were verified by experimental studies. Firstly, a total of 1480 predicted target points were obtained through the Swiss Target Prediction database. After screening, merging, and deleting duplicate values, a total of 768 targets were obtained. Secondly, “Coronary atherosclerotic heart disease” was searched in databases such as the OMIM, GeneCards, and TTD. 1844 disease-related targets were obtained. Among PPI network diagram of YHHR-CAD, SRC had the highest degree value, followed by AKT1, TP53, hsp90aa1 and mapk3. The KEGG pathway bubble diagram was drawn using Chiplot, the Signal pathways such as NF kappa B signaling pathway, Lipid and AS, and Apelin signaling pathway are closely related to the occurrence of CAD. The PCR and Western blot methods were used to detect the expression of NF-κB p65. When compared with that in the model group, the expression of NF-κB p65mRNA decreased in the low-concentration YHHR group, with P &lt; .05, while the expression of NF-κB p65mRNA decreased significantly in the high-concentration YHHR group, with P &lt; .01. On the other hand, when compared with that in the model group, the expression of NF-κB p65 decreased in the low-concentration YHHR group, but was not statistically significant, while the expression of NF-κB p65 was significant in the high-concentration YHHR group, and has statistical significance with P &lt; .05. YHHR has been shown to resist inflammation and AS through the SRC/NF-κB signaling pathway.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000034178</identifier><identifier>PMID: 37390239</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Observational Study</subject><ispartof>Medicine (Baltimore), 2023-06, Vol.102 (26), p.e34178-e34178</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3</citedby><cites>FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313272/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313272/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37390239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Hong-Tao</creatorcontrib><creatorcontrib>Lv, Wen-Qing</creatorcontrib><creatorcontrib>Xu, Fei-Yue</creatorcontrib><creatorcontrib>Wang, Xiao-Long</creatorcontrib><creatorcontrib>Yao, Yi-Li</creatorcontrib><creatorcontrib>Su, Li-Jie</creatorcontrib><creatorcontrib>Zhao, Han-Jun</creatorcontrib><creatorcontrib>Huang, Yu</creatorcontrib><title>Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>In recent years, with population aging and economic development, morbidity and mortality of atherosclerotic cardiovascular disease associated with atherosclerosis (AS) have gradually increased. In this study, a combination of network pharmacology and experimental verification was used to systematically explore the action mechanism of Yiqi Huoxue Huatan Recipe (YHHR) in the treatment of coronary atherosclerotic heart disease (CAD). We searched and screened the active ingredients of Coptis chinensis, Astragalus membranaceus, Salvia miltiorrhiza, and Hirudo. We also searched multiple databases for related target genes corresponding to the compounds and CAD. STRING was used to construct the protein-protein interaction (PPI) network of genes. Metascape was used to perform gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for common targets to analyze the main pathways, and finally, the molecular docking and main possible pathways were verified by experimental studies. Firstly, a total of 1480 predicted target points were obtained through the Swiss Target Prediction database. After screening, merging, and deleting duplicate values, a total of 768 targets were obtained. Secondly, “Coronary atherosclerotic heart disease” was searched in databases such as the OMIM, GeneCards, and TTD. 1844 disease-related targets were obtained. Among PPI network diagram of YHHR-CAD, SRC had the highest degree value, followed by AKT1, TP53, hsp90aa1 and mapk3. The KEGG pathway bubble diagram was drawn using Chiplot, the Signal pathways such as NF kappa B signaling pathway, Lipid and AS, and Apelin signaling pathway are closely related to the occurrence of CAD. The PCR and Western blot methods were used to detect the expression of NF-κB p65. When compared with that in the model group, the expression of NF-κB p65mRNA decreased in the low-concentration YHHR group, with P &lt; .05, while the expression of NF-κB p65mRNA decreased significantly in the high-concentration YHHR group, with P &lt; .01. On the other hand, when compared with that in the model group, the expression of NF-κB p65 decreased in the low-concentration YHHR group, but was not statistically significant, while the expression of NF-κB p65 was significant in the high-concentration YHHR group, and has statistical significance with P &lt; .05. YHHR has been shown to resist inflammation and AS through the SRC/NF-κB signaling pathway.</description><subject>Observational Study</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkc9u1DAQxi1ERZfCEyAhH7mk-G-8OSHUAkXqqhc4cLIce7IxTeLUdtjyBjw23m4pUB880sxvvhn7Q-gVJaeUNOrt5vyU_D1cULV-glZU8rqSTS2eohUhTFaqUeIYPU_pOyGUKyaeoWOueEMYb1bo1wZsbyafRhw6_M3feHyxhNsFSjDZTDiC9TNgP-HcA84RTB5hynvahhgmE39iU0oxJDuUO3uLnU9gUqH7GJZtjyfIuxCv8dybOBobhrAtTZPDcDtD9Hu99AIddWZI8PI-nqCvHz98ObuoLq8-fT57f1lZISmtQNWSAkBXg1DcUUtb6TpBO1AWOuJk6yyvzVqKVjWtlLa1DXOmk25dO9G1_AS9O-jOSzuCs2V2NIOeyxrlKToYr_-vTL7X2_BDU8IpZ4oVhTf3CjHcLJCyHn2yMAxmgrAkzdacycKxpqD8gNryPSlC9zCHEr03UW_O9WMTS9frf1d86PnjWgHEAdiFIUNM18Oyg6h7MEPu7_SkaljFCkxqTkhVMpTy38qlrPQ</recordid><startdate>20230630</startdate><enddate>20230630</enddate><creator>Huang, Hong-Tao</creator><creator>Lv, Wen-Qing</creator><creator>Xu, Fei-Yue</creator><creator>Wang, Xiao-Long</creator><creator>Yao, Yi-Li</creator><creator>Su, Li-Jie</creator><creator>Zhao, Han-Jun</creator><creator>Huang, Yu</creator><general>Lippincott Williams &amp; Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230630</creationdate><title>Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments</title><author>Huang, Hong-Tao ; Lv, Wen-Qing ; Xu, Fei-Yue ; Wang, Xiao-Long ; Yao, Yi-Li ; Su, Li-Jie ; Zhao, Han-Jun ; Huang, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Observational Study</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Hong-Tao</creatorcontrib><creatorcontrib>Lv, Wen-Qing</creatorcontrib><creatorcontrib>Xu, Fei-Yue</creatorcontrib><creatorcontrib>Wang, Xiao-Long</creatorcontrib><creatorcontrib>Yao, Yi-Li</creatorcontrib><creatorcontrib>Su, Li-Jie</creatorcontrib><creatorcontrib>Zhao, Han-Jun</creatorcontrib><creatorcontrib>Huang, Yu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Hong-Tao</au><au>Lv, Wen-Qing</au><au>Xu, Fei-Yue</au><au>Wang, Xiao-Long</au><au>Yao, Yi-Li</au><au>Su, Li-Jie</au><au>Zhao, Han-Jun</au><au>Huang, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2023-06-30</date><risdate>2023</risdate><volume>102</volume><issue>26</issue><spage>e34178</spage><epage>e34178</epage><pages>e34178-e34178</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>In recent years, with population aging and economic development, morbidity and mortality of atherosclerotic cardiovascular disease associated with atherosclerosis (AS) have gradually increased. In this study, a combination of network pharmacology and experimental verification was used to systematically explore the action mechanism of Yiqi Huoxue Huatan Recipe (YHHR) in the treatment of coronary atherosclerotic heart disease (CAD). We searched and screened the active ingredients of Coptis chinensis, Astragalus membranaceus, Salvia miltiorrhiza, and Hirudo. We also searched multiple databases for related target genes corresponding to the compounds and CAD. STRING was used to construct the protein-protein interaction (PPI) network of genes. Metascape was used to perform gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for common targets to analyze the main pathways, and finally, the molecular docking and main possible pathways were verified by experimental studies. Firstly, a total of 1480 predicted target points were obtained through the Swiss Target Prediction database. After screening, merging, and deleting duplicate values, a total of 768 targets were obtained. Secondly, “Coronary atherosclerotic heart disease” was searched in databases such as the OMIM, GeneCards, and TTD. 1844 disease-related targets were obtained. Among PPI network diagram of YHHR-CAD, SRC had the highest degree value, followed by AKT1, TP53, hsp90aa1 and mapk3. The KEGG pathway bubble diagram was drawn using Chiplot, the Signal pathways such as NF kappa B signaling pathway, Lipid and AS, and Apelin signaling pathway are closely related to the occurrence of CAD. The PCR and Western blot methods were used to detect the expression of NF-κB p65. When compared with that in the model group, the expression of NF-κB p65mRNA decreased in the low-concentration YHHR group, with P &lt; .05, while the expression of NF-κB p65mRNA decreased significantly in the high-concentration YHHR group, with P &lt; .01. On the other hand, when compared with that in the model group, the expression of NF-κB p65 decreased in the low-concentration YHHR group, but was not statistically significant, while the expression of NF-κB p65 was significant in the high-concentration YHHR group, and has statistical significance with P &lt; .05. YHHR has been shown to resist inflammation and AS through the SRC/NF-κB signaling pathway.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>37390239</pmid><doi>10.1097/MD.0000000000034178</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2023-06, Vol.102 (26), p.e34178-e34178
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10313272
source HEAL-Link subscriptions: Lippincott Williams & Wilkins; IngentaConnect Journals; PubMed Central
subjects Observational Study
title Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T06%3A17%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20of%20Yiqi%20Huoxue%20Huatan%20recipe%20in%20the%20treatment%20of%20coronary%20atherosclerotic%20disease%20through%20network%20pharmacology%20and%20experiments&rft.jtitle=Medicine%20(Baltimore)&rft.au=Huang,%20Hong-Tao&rft.date=2023-06-30&rft.volume=102&rft.issue=26&rft.spage=e34178&rft.epage=e34178&rft.pages=e34178-e34178&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000034178&rft_dat=%3Cproquest_pubme%3E2832572329%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4511-e7651eeef6e473d1c1b5df41fe7cef0d5bdc36a854b79b55cbc92daf5d86d4fb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2832572329&rft_id=info:pmid/37390239&rfr_iscdi=true